Credit: Getty Images. Insulin glargine 300 Units/mL was found to be comparable to insulin glargine 100 Units/mL in providing effective glycemic control in pediatric patients with type 1 diabetes.

ORLANDO -- Most adults with type 1 diabetes switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) needed to increase their dose of the inhaled product to achieve ...

The FINANCIAL — Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals, Inc. announced on December 15 that BASAGLAR (insulin glargine injection 100 units/mL) is available by prescription in ...

Please provide your email address to receive an email when new articles are posted on . Hospitalized patients who require strict glycemic control may now be able to receive IV insulin while in an ...

Purpose: An insulin infusion protocol for critical care units is described. Summary: Evidence that aggressive glycemic control improves outcomes led physicians, nurses, dietitians, and pharmacists at ...

The average price per insulin unit hit a 10-year low in 2024, largely driven by federal actions and voluntary price cuts from drugmakers, according to a Jan. 15 GoodRx report. GoodRx analyzed the ...

TRENTON, N.J. — Preliminary research suggesting that some diabetes patients may be injecting medicine that has partially disintegrated is causing concern even as serious questions are raised about the ...

The pharmacy benefit manager, Optum Rx, a sub-unit of UnitedHealth Group Incorporated’s UNH segment Optum, recently transferred eight products to tier one on its standard formulary. The shifted ...

Sanofi (Euronext: SAN; NYSE: SNY) announced today that it received FDA approval for its Toujeo Max SoloStar insulin pen, the highest capacity long-acting insulin pen that will be available on the ...

The development of an insulin infusion protocol was initiated by key contributors from a team of nurses, dietitians, pharmacists, and physicians. The physician members were from various specialties, ...